
Jeffrey Glenn
Director, Center for Hepatitis and Liver Tissue Engineering · Stanford Health Care
Credentials: · · ·
History
PresentCenter for Hepatitis and Liver Tissue Engineering · Stanford Health Care
Present
Present
1995–1998
1993–1995- 1989–1993
University of California at San Francisco School of Medicine (1993) CA
Research
A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures
Nature · 2020 · 555 citations
Progenitor identification and SARS-CoV-2 infection in human distal lung organoids
Nature · 2020 · 330 citations
Structure of the neurotensin receptor 1 in complex with β-arrestin 1
Nature · 2020 · 324 citations
- EP
14 papers · 10 as a resident
- CK
13 papers
- TH
12 papers
- RG
10 papers

9 papers

8 papers · 7 as a resident
- OE
6 papers
- PP
6 papers
Grants
- 2020–2030
Clinical Research Products Management Center (CRPMC)
NIH Office of the Director · N01
Contact PI · $27.9M · Fisher Bioservices, Inc.
- 2022–2028
National Institute of Allergy and Infectious Diseases · U19
Contact PI · $81.2M · Stanford University
- 2026–2027
Advancing a Novel Oral Anti-IAV Therapeutic to the Clinic
National Institute of Allergy and Infectious Diseases · R56
Contact PI · $1.3M · Stanford University
- 2021–2026
Optimizing a Small Molecule Inhibitor of SARS-CoV-2 Replication and Associated Cytokine Storm
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $3.8M · Stanford University


